Fig. 4From: Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editingViral vector technology development and its application to human gene therapy. The line represents the timeline of this technology, from the 1960s to now. Adapted from [59]Back to article page